For example, use of selective estrogen receptor modulators, such as tamoxifen and raloxifene, has been shown to reduce dramatically the incidence of breast cancer in women who are at a high risk for developing the disease (Umar et al. 2012; Den Hollander et al. 2013). This evidence concerns the gene ESR1 and breast cancer.